$18.88
▲ +2.2% Today
as of Sep 4, 16:55 ET
Last 30 days
Recent Press Releases & News
lean bull
▲ 4
● 21
▼ 0
Takeda Pharmaceutical Insider Sold Shares Worth $2,148,372, According to a Recent SEC Filing
Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?
Takeda and Weave Bio collaborate on AI-driven automation in drug development
Overview
52-week range
$13
$19
100% of range
Avg surprise (last 3)
+3.5%
Avg reaction (last 2)
-2.0%
50% positive
Latest IV / EM
80%
EM ±12.5% · $18 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $0.28 | $0.21 | +33.3% | +75.0% | +1.3% | earnings |
| Wed Jul 30, 2025 | Jun/2025 | $0.52 | $0.47 | +10.6% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $0.16 | $0.24 | -33.3% | — | -5.2% | earnings |